N-[4-Chloro-2-methoxy-5-(1-methylethenyl)phenyl]acetamide, 97%, 250mg

3-Bromo-4-methyl-5-(methylthio)pyridine, 95%, 1g

2,5-Dibromothiophene-3,4-dicarboxylic acid, 95.0%, 5g

Ambrisentan>98.0%(HPLC)100mg

N-[2-(4-Morpholino)phenyl]-2-chloropropanamide, 95%, 2g

Silicon powder, amorphous 99.999% -100, +325 mesh 250 g

(4-Fluorophenyl)glyoxylic acid, 97.0%, 10g

2-Ethylimidazole, 97.0%, 250g

3-BROMO-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDINE DIHYDROCHLORIDE, 95.0%, 250mg

1-(4'-Hydroxy-[1,1'-biphenyl]-4-yl)ethanone, 97%, 10g

Accessories exchange block for reaction vessels, Gesch. for, 20 reaction vessels 2.0 ml, 1 piece

(S)-Ethyl 2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoacetate (Afatinib Impurity), 98%, 50mg

Bismuth(III) chloride, min. 97%, extra pure, 50 g, plastic packaging.